X4 PHARMACEUTICALS INC (XFOR) Stock Earnings & Estimates
NASDAQ:XFOR - US98420X1037 - Common Stock
3.82 USD
-0.15 (-3.78%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.557M | 36.152M 1,313.84% | 21.824M -39.63% | 114.08M 422.73% | 118.82M 4.15% | 199.46M 67.87% | 298M 49.40% | 388.63M 30.41% | 409.63M 5.40% | |||
| EBITDA YoY % growth | -87.57M -16.99% | -107.103M -22.31% | -140.605M -31.28% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -88.08M -16.89% | -107.522M -22.07% | -141.401M -31.51% | -83.363M 41.04% | -99.037M -18.80% | -43.502M 56.07% | -49.48M -13.74% | -4.433M 91.04% | 66.992M 1,611.12% | 130.13M 94.25% | 135.76M 4.33% | |
| Operating Margin | N/A | N/A | -5,529.96% | -230.59% | -453.80% | -38.13% | -41.64% | -2.22% | 22.48% | 33.48% | 33.14% | |
| EPS YoY % growth | -56.10 49.46% | -18.00 67.91% | -21.30 -18.33% | -4.90 76.99% | -2.95 39.84% | -0.34 88.32% | -1.14 -230.37% | -0.66 42.15% | 0.21 132.56% | 0.96 350.00% | 2.67 177.25% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.60 51.80% | -1.79 70.22% | -0.57 -1,519.51% | -0.57 83.64% | -0.52 79.89% | -0.50 72.03% |
| Revenue Q2Q % growth | 2.149M 283.75% | 2.721M 89.75% | 3.162M -89.02% | 3.808M 93.01% | 4.182M 94.60% | 4.488M 64.94% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.207M 29.84% | -22.315M 37.52% | -24.284M -157.16% | -24.263M 7.51% | -25.327M -4.63% | -25.74M -15.35% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.47 -65.24% | -4.42 | 0.95 | 21.58% |
| Q1 2025 Q2Q % growth | 0.04 100.51% | -4.53 | 4.57 | 100.88% |
| Q4 2024 Q2Q % growth | -6.00 -100.00% | -5.36 | -0.64 | -12.04% |
| Q3 2024 Q2Q % growth | -5.40 -1,700.00% | -5.29 | -0.11 | -2.09% |
| Q2 2024 Q2Q % growth | -2.10 78.79% | 0.17 | -2.27 | -1,301.88% |
| Q1 2024 Q2Q % growth | -7.80 -62.50% | -4.98 | -2.82 | -56.52% |
| Q4 2023 Q2Q % growth | -3.00 65.52% | -4.68 | 1.68 | 35.86% |
| Q3 2023 Q2Q % growth | -0.30 96.15% | -4.56 | 4.26 | 93.42% |
| Q2 2023 Q2Q % growth | -9.90 45.00% | -5.00 | -4.90 | -98.08% |
| Q1 2023 Q2Q % growth | -4.80 77.78% | -6.64 | 1.84 | 27.76% |
| Q4 2022 Q2Q % growth | -8.70 67.78% | -7.38 | -1.32 | -17.85% |
| Q3 2022 Q2Q % growth | -7.80 65.79% | -9.16 | 1.36 | 14.81% |
| Q2 2022 Q2Q % growth | -18.00 18.92% | -19.54 | 1.54 | 7.88% |
| Q1 2022 Q2Q % growth | -21.60 44.62% | -18.62 | -2.98 | -15.99% |
| Q4 2021 Q2Q % growth | -27.00 1.10% | -20.90 | -6.10 | -29.21% |
| Q3 2021 Q2Q % growth | -22.80 -2.70% | -22.11 | -0.69 | -3.13% |
| Q2 2021 Q2Q % growth | -22.20 2.63% | -22.61 | 0.41 | 1.79% |
| Q1 2021 Q2Q % growth | -39.00 -132.14% | -26.28 | -12.72 | -48.42% |
| Q4 2020 Q2Q % growth | -27.30 -37.88% | -27.63 | 0.33 | 1.20% |
| Q3 2020 Q2Q % growth | -22.20 21.28% | -23.12 | 0.92 | 3.99% |
| Q2 2020 Q2Q % growth | -22.80 25.49% | -21.95 | -0.85 | -3.88% |
| Q1 2020 Q2Q % growth | -16.80 | -24.40 | 7.60 | 31.15% |
| Q4 2019 Q2Q % growth | -19.80 | -25.44 | 5.64 | 22.18% |
| Q3 2019 Q2Q % growth | -28.20 | -32.71 | 4.51 | 13.79% |
| Q2 2019 Q2Q % growth | -30.60 | -29.28 | -1.32 | -4.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.973M 250.44% | 1.644M | 329K | 20.01% |
| Q1 2025 Q2Q % growth | 28.807M | 2.038M | 26.769M | 1,313.49% |
| Q4 2024 Q2Q % growth | 1.434M | 1.062M | 372K | 35.03% |
| Q3 2024 Q2Q % growth | 560K | 1.727M | -1.167M | -67.57% |
| Q2 2024 Q2Q % growth | 563K | 284.243K | 278.757K | 98.07% |
| Q1 2022 Q2Q % growth | 123.859K | -123.859K | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 18.15% | 27.88% | 49.66% | 56.35% |
| Revenue | 2.19% | -26.15% | 0.98% | 39.17% |